This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Laurence Mosbach-Ozmen: Innovator in Alzheimer’s Research
Introduction
Laurence Mosbach-Ozmen is a prominent inventor based in Saint-Louis, France. She has made significant contributions to the field of biomedical research, particularly in the study of amyloidopathies and Alzheimer’s disease. Her innovative work has led to the development of a novel animal model that aids in understanding the complexities of neurodegeneration.
Latest Patents
Laurence holds a patent for "Double transgenic mice overexpressing human beta secretase and human APP-London." This invention relates to a unique animal model for amyloidopathies, especially Alzheimer’s disease, which overexpresses human BACE and human APP London. The model exhibits several aspects of amyloidopathy, providing a valuable tool for research. The patent also includes methods for producing these double transgenic animals, as well as cells and cell lines derived from them. Furthermore, it outlines a method for evaluating the in vivo effects of beta-secretase activity on A-beta peptide generation, amyloidosis, neurodegeneration, and Alzheimer’s disease pathology.
Career Highlights
Laurence has dedicated her career to advancing the understanding of Alzheimer’s disease through innovative research. Her work has been recognized for its potential to contribute to the development of therapeutic strategies for combating neurodegenerative diseases. She is currently associated with Hoffmann-La Roche Inc., where she continues to push the boundaries of scientific discovery.
Collaborations
Laurence has collaborated with notable colleagues, including Peter Nelboeck-Hochstetter and Helmut Jacobsen. These partnerships have enhanced her research efforts and contributed to the advancement of knowledge in the field of Alzheimer’s disease.
Conclusion
Laurence Mosbach-Ozmen is a trailblazer in Alzheimer’s research, with her innovative patent providing critical insights into amyloidopathies. Her contributions to the scientific community are invaluable, and her work continues to inspire future research in neurodegeneration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile